Table 2.
Variable | No Age Cutoff |
80 Years |
70 Years |
60 Years |
50 Years |
|||||
---|---|---|---|---|---|---|---|---|---|---|
100% Acceptance Rate | 50% Acceptance Rate | 100% Acceptance Rate | 50% Acceptance Rate | 100% Acceptance Rate | 50% Acceptance Rate | 100% Acceptance Rate | 50% Acceptance Rate | 100% Acceptance Rate | 50% Acceptance Rate | |
Total cost to screen and test this age cohort | $113,123 | $100,711 | $97,808 | $87,076 | $72,747 | $64,765 | $46,293 | $41,214 | $17,752 | $15,804 |
No. of LS cases present in entire CRC cohort | 11.7 | 11.7 | 11.7 | 11.7 | 11.7 | 11.7 | 11.7 | 11.7 | 11.7 | 11.7 |
No. of LS cases expected in screened cohort | 11.7 | 11.7 | 11.2 | 11.2 | 10.1 | 10.1 | 9.0 | 9.0 | 5.9 | 5.9 |
Mean No. of LS cases expected to be identified in screened cohort | 10.7 | 5.4 | 10.2 | 5.1 | 9.2 | 4.6 | 8.3 | 4.1 | 5.4 | 2.7 |
Cost per LS case detected in screened cohort | $10,567 | $18,794 | $9567 | $17,016 | $7865 | $3989 | $5594 | $9950 | $3316 | $5899 |
No. of LS cases missed if screening cut off at this age | 1.0 | 6.3 | 1.5 | 6.6 | 2.5 | 7.1 | 3.4 | 7.6 | 6.3 | 9.0 |
No. of LS cases expected to be missed in screened cohort | 1.0 | 6.3 | 0.9 | 6.1 | 0.9 | 5.5 | 0.8 | 4.9 | 0.5 | 3.2 |
LS cases that would be missed with this strategy, % | 8.5 | 54.2 | 12.6 | 56.3 | 20.9 | 60.4 | 29.3 | 64.6 | 54.3 | 77.1 |
NOTE. Boldface indicates parameters the authors believe to be most important in the age cutoffs reviewed in the Discussion section.
Abbreviations: CRC, colorectal cancer; LS, Lynch syndrome.